<DOC>
	<DOCNO>NCT00201786</DOCNO>
	<brief_summary>This study evaluate response rate treatment pentostatin steroid-refractory acute graft versus host disease .</brief_summary>
	<brief_title>Phase II Trial Pentostatin Steroid Refractory Acute Graft Versus Host Disease</brief_title>
	<detailed_description />
	<mesh_term>Graft v Host Disease</mesh_term>
	<mesh_term>Pentostatin</mesh_term>
	<criteria>Must biopsy proven grade IIIV acute GVHD refractory systemic corticosteroid No chronic GVHD Age ≥ 18 year Evidence myeloid engraftment ( ANC ≥ 0.5 x 109/l ) Performance status 03 Patients mechanical ventilation rest O2 saturation &lt; 90 % pulseoximetry . Patients renal dialysis estimate creatinine clearance &lt; 30 ml/min/1.73 m2 . Patients document clinical infection ( progressive symptom despite antibiotic continue fever ) enrol study infection control .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>Corticosteroids</keyword>
</DOC>